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The development of molecular biology and molecular genetics, 
especially of the recombinant DNA technology enabled improvement of 
experimental methods that provide manipulation within a cell-free sys-
tem, such as cell and tissue cultures. Such methods resulted in the devel-
opment of different new technologies with specific properties in relation 
to the conventional definitions. According to PERSLEY and LANTIN (2000) 
the following components are essential for the contemporary biotechnol-
ogy: (i) genomics – a molecular characterization of all genes and gene 
products of an organism; (ii) bioinformatics – the assembly of data from 
genomic analysis into accessible forms; (iii) transformation – the intro-
duction of genes controlling a trait of interest into a genome of a desired 
organism (micro organisms, plants, animal systems). By the application 
of cotemporary biotechnology new methods in the field of diagnostic are 
developed such as rapid and more accurate identification of the presence 
and absence of genes in the genome of the organism of interest (identifi-
cation of pathogens, prenatal diagnostics, molecular markers assisted 
breeding for plants, etc.). The traits of an organism are determined by its 
genetic material, i.e. by a molecule of deoxyribonucleic acid (DNA). 
WATSON and CRICK (1953) were the first scientists to describe the struc-
ture of DNA as a double-stranded helix. Higher organisms contain a set of 
linear DNA molecules - chromosomes and a full set of chromosomes of 
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an organism is a genome. Each genome is divided into a series of func-
tional units, i.e. genes. The traits of an organism depend on genes, but 
their expression depends not only on genes, but also on many other fac-
tors, including whether a gene, controlling the trait, expresses, specific 
cells in which it expresses and specially the mode by which the gene and 
its product interact with the environment. A special aspect within the ap-
plication of biotechnology occurs as an interaction of a foreign gene with 
a genome of an integrated organism. Also, application of biotechnology 
provides transfer of one or several favorable genes from any evolutionary 
category into other category of an organism and in such a way it is possi-
ble to develop genetically modified organisms (GMO) having expressed 
desired, target traits. A survey of the application of biotechnology in the 
world and our country is presented in this paper. 
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INTRODUCTION 
At the end of the 20th century agriculture entered a new technological era: 
biotechnology integrated scientific branches such as biology, biochemistry, mo-
lecular biology, genetics, chemical engineering and informatics. Discoveries within 
these fields opened up new horizons in prevention of plant and animal diseases, 
pesticide-free insect control, livestock efficiency increase, increase of production 
and improvement of food quality and reduction of environmental degradation. 
Functional genomics is one of the essential factors behind this revolution, 
as it uses a scientific approach for identification, definition of gene functions and 
determination where and how genes mutually function in control of a particular 
trait. The cotemporary approach essentially presenting study on a genome structure 
(e.g. mapping), is generally aimed at traits controlled by one gene or a small num-
ber of genes and therefore provided information is often mostly related to a gene 
location in the genome. Although information on the gene location is a critical 
point, the determination of a gene function provides possibilities to study relations 
and interactions among several thousands genes. In such a way, the background for 
investigation when and why a specific trait expresses, which sets of genes specifi-
cally govern the expression of such a trait and under which conditions is set up. 
Obtained pieces of information enable researches with a possibility to develop 
economically important plants whose genome encompasses specifically modified 
and by genomic transformation integrated genes, affecting traits that allow growing 
under different environments. Among many several traits such as tolerance to high 
and low temperatures or saline and acid soils, resistance to pathogenic micro or-
ganisms or the synthesis of substances of interest for the production of food of a 
higher quality. At the same time, the application of new biotechnology provides the 
determination of a potential or actual risk of consumption of food produced from 
genetically modified plants, which is a prerequisite for biosafety that will provide 
minimization or complete elimination of risk. 
K.KONSTANTINOV et al.: BIOTECHNOLOGY: REALITY OR DREAM 103 
BIOTECHNOLOGY – DEFINITION AND APPLICATION WITHIN PLANT 
BREEDING 
According to the Convention on Biological Diversity (CBD), biotechnol-
ogy means "the application of any technology that uses biological systems, living 
organisms or their derivates with the aim to produce - develop - or modify products 
or processes of specific purposes". Genetic modifications defined by CPB (Cart-
agena Protocol on Biosafety) acts exclude other old or new techniques that lead to 
changes of genotypes (CARTAGENA PROTOCOL ON BIOSAFETY, 2000). Interpreted 
in such a way the definition encompasses a great number of tools and methods that 
are practically applied within fields of agriculture and food production. According 
to PERSLEY and LANTIN (2000) the following presents the essential components of 
contemporary biotechnology: 
- molecular characterization of all genes and gene products of an organism 
- bioinformatics - the assembly of data from genomic analysis into acces-
sible forms  
- transformation - the introduction of a gene conferring potentially useful 
traits into plant, animal or genome of micro organisms 
- molecular breeding - the use of molecular markers for the breeding 
process improvement  
- diagnostics - rapid and more accurate identification of pathogens based 
on molecular characterization  
Genetic modifications of plants, as well as, conventional breeding have 
the same goal - to develop plants with improved traits. A full set of genes is trans-
ferred from parental lines into a progeny by conventional breeding methods. In 
such a way not only one or two favorable genes, but also hundreds of others, some 
favorable some unfavorable, are transferred. In addition, the conventional breeding 
methods are based on transfer of genetic material among individuals of the same or 
very close species. 
The application of biotechnology (genetic engineering and cell and tissue 
culture) has several advantages over conventional plant breeding and the key ad-
vantage is that it is possible to transfer one or several favorable genes from any 
plant species, micro organisms, animal systems into a target plant and vice versa 
and in such a way it is possible to develop genetically modified plants (GMP).  
GENETICALLY MODIFIED PLANTS 
The presence of DNA molecules within all cells of organisms is the base 
for the development of genetically modified organisms including plants. The traits 
of an organism are determined by its genetic material, i.e. by a molecule of deoxy-
ribonucleic acid (DNA) as a double-stranded helix (WATSON and CRICK, 1953). 
This molecule encompasses genetic information and governs metabolic processes. 
Genes are discrete segments of DNA containing information necessary for the 
formation of a specific protein. Proteins in cells function as enzymes in biochemi-
cal reactions or as structural or depot units, contributing to the expression of a spe-
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cific trait. Processes of transcription and translation, controlled by a set of regula-
tory mechanisms in a way that a particular protein is synthesized only where and 
when it is needed, are included into transfer of information from DNA to a protein. 
Very divergent species have a similar mechanism on translation of genetic infor-
mation from a DNA into a protein; hence a DNA sequence can be transferred from 
bacteria into a plant cell where it can also function. 
Results of ARBER et al. (1983) obtained within a system of bacterial vi-
ruses showed that restriction enzymes, isolated from bacteria, could be used for a 
precise sectioning of the DNA molecule in specific sites defined as sequences of 
four, five and six nucleotides, presenting a basis of the development of the new 
recombinant DNA technology. If DNA ligase, an enzyme that catalyses the joining 
of two ends of DNA is used, DNA fragments can be joined (stuck together) into a 
new molecule of the altered structure. If cohesive fragments belong to different 
organisms, their cohesion results into a recombined DNA molecule, which is used 
for a gene transfer in the process of transformation to get genetically modified or-
ganisms (GMO). 
The processes involved in developing genetically modified plants are the 
following:  
- identification and isolation of the desired gene, 
- gene cloning,  
- development of transgenes,  
- gene transfer and  
-  introduction into breeding processes.  
The identification of a single gene is not sufficient - it is necessary to be 
acquainted with regulatory mechanisms of gene actions, as well as, with their sec-
ondary effects and interactions with other genes. Prior to this, it is necessary to 
identify an organism containing the desired gene in its genome. A little is known 
about specific genes affecting plant traits such as yield, stress tolerance, disease 
resistance etc.  
Arabidopsis thaliana is a plant of the Cruciferae family with only five 
chromosomes having progenies in only seven weeks. Due to a great similarity 
among plants, Arabidopsis can be used as a model system and sequences of genes 
of this plant, and known functions could be used as molecular - DNA markers in 
the identification and localization of homologous sequences in genomes of other 
plant species. Some of such markers can be used for the identification of chromo-
somal regions containing genes that code quantitative traits including tolerance to 
soil salinity (ZHU, 2000). 
Tobacco plants, transformed by the use of Ti - plasmids of the bacterium 
Agrobacterium tumefaciens as a vector, were the first transgenic plants with active 
foreign genes introduced by methods of biotechnology (HORSCH et al., 1984; 
DEBLOCK et al., 1984). The transformation was confirmed by the presence of a 
foreign DNA sequence in the primary transgenic plants and their progenies. Beside 
gene integration and vertical transmission, the expression of the introduced gene, 
governing resistance of transgenic plants to the antibiotic neomycin, was deter-
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mined. This resistance is a result of the action of a marker gene used in transfor-
mation which controls the synthesis of the enzyme neomycin phosphotrasferase 
that inactivates the neomycin activity by phosphorylation. The transformation was 
performed in the initial experiments by the introduction of genes into protoplasts, 
while POTRYCUS (1990) reviewed the majority of used efficient methods. In our 
experiments, the same marker gene controlling activity of the enzyme neomycin 
phosphotransferase (NPT II) was used for maize transformation by the application 
of three different methods: microinjection into archesporial tissue of several cell 
divisions prior to meiosis, co-cultivation of dry seed in the solution of plasmid 
DNA and the use of pollen grain as a carrier of plasmid DNA (KONSTANTINOV et 
al., 1993). 
The accessibility of efficient systems of transformation of cultivated 
plants is important for plant breeding. The initial studies were aimed at the intro-
duction of genes controlling resistance to insects, herbicides and micro organism’s 
disease-producing agents. Progress was very rapid and genes controlling these 
traits have been already successfully integrated into several economically impor-
tant plants species, such as maize, soybean, cotton, oil seed rape, sugar beet, to-
mato, alfalfa that are commercially grown on large areas (JAMES, 2001). Subse-
quent studies encompassed changes of a trait whose expression depended on the 
developmental stage and differentiation of tissues and organs. 
Dramatic progress in the development of transfer systems of genes into 
plant organisms and the possibility of regeneration of vital fertile plants established 
conditions for the introduction of foreign genes, controlling useful plant traits, sig-
nificant increase of genetic yield potential and therefore the food production in-
crease. Besides, transgenic plants, synthesizing specific substances of importance 
for pharmaceutical industry, were developed.  
GENETICALLY MODIFIED CROPS AND RISKS IN CONSUMPTION OF 
FOOD PRODUCED FROM THESE CROPS 
Food does not only satisfy the elementary physiological needs, but it is 
also related to contentment and recovery and therefore any indication that any of 
food components may carry a risk to health has to be avoided. 
Genetically modified plants provide food industry with a possibility to 
produce new products with significantly lower investments. The examples of such 
production are the following: (i) great quantities of starch of special types or starch 
with altered structure or chain length providing extended storage; (ii) greater 
amounts of specific oils or elimination of certain fat acids in plant oil and (iii) pro-
teins with the balanced amino acids content. Enzymes and genes involved into bio-
synthesis of dyes and scents are of importance for both, food industry and consum-
ers of such produced food. 
The effect of products derived from genetically modified plants on human 
health depends on specific chemical composition of the product itself. Products for 
instance with the increased content of digestible iron or if substances causing al-
lergy is removed from it can be potentially useful, while it can be harmful if ge-
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netic modification introduced new allergen or toxin that remained during the pro-
duction process (WEKSLER, 2000). Genetic manipulation can cause that a new al-
lergen can be introduced into food not only from the known source of allergenicity, 
but also from plants, bacteria or viruses whose potential allergenicity is unknown. 
Due to it, the studies on allergenicity are a compulsory part of the investigation 
process of safety of products derived by processing of genetically modified plants. 
The example of the consumers' respond to potential risks is a movement 
of consumers in England related to the implication that can arise from a well 
known study of effects of feeding rats on genetically modified potato. The studies 
showed that potato modified to synthesize a protein toxic to animals could have 
adverse effects on some organs and the immune system (RUCKMAN, 2002).  
Having sufficient information on specificities of the integrated DNA gene 
sequence, a detailed comprehension of functions of gene products and a high level 
of knowledge on biological and chemical traits are stated to be key reasons for low 
risks for human and animal health in consumption of food obtained by processing 
of GMO. 
There are three levels of the potential risk: i) a promoter sequence, a con-
stituent part of a construct, as it is a key factor in gene expression; ii) a sequence of 
a marker gene that is a constituent part of the construct and has a role in the selec-
tion of a transformant and iii) a coding sequence of a gene that is introduced during 
transformation.  
In recent times intensive studies on risk caused by promoter sequences of 
bacteria and viruses, a constituent active part encompassing a gene of interest in-
troduced into a heterologous organism, have been performed. A promoter sequence 
(35S) of a gene of cauliflower mosaic virus was used in experiments of transfor-
mation of the majority of plant species commercially grown. HO et al. (1999) 
pointed out to the risk that this sequence could activate or inactivate the expression 
of genes of a host plant or endogenous viruses then could recombine with mam-
malian viruses with unpredictable consequences. Genes whose introduction 
changes existing biochemical processes, including genetic manipulation of regula-
tory genes, are a special approach. The isolation of large bacteria with regulatory 
sequences provides reliable gene expressions within specific tissues of transgenic 
plants. 
The possibility of a gene expression reduction in transgenic plants has a 
significant role in studies on the gene expression and function, as well as, plant 
breeding. Results of studies on insertion of DNA donors into plant chromosomes 
by homologous recombination (PASZKOWSKI et al., 1988) show that it is possible 
to use this approach in selective gene inactivation.  
In our experiments performed to develop transgenic plants, introduced 
marker gene (NPT II) induced changes in activities of particular loci, controlling 
isoenzymic activity and complex of soluble proteins. These changes were deter-
mined in the germ of mature maize kernel (MLADENOVIĆ et al., 1991). 
Genetically modified plants used in food production provide consumers 
not only with satisfaction of the basic function of a nutrient, but also with many 
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improvements, such as a reduction of the allergen content or the increase of the 
amounts of vitamins and other vital substances (YE et al., 2000; LUCCA et al., 
2001). One of example is margarine produced from plants having increased plant 
sterol content which lowers the synthesis of cholesterol. Another good example is 
cereals with the increased content of iron and vitamin B12. Rice, contrary to 
barely, is extremely susceptible to iron deficiency. Its transformation was per-
formed by a fragment of barely genomic DNA containing two naat genes that are 
coding the synthesis of a key enzyme involved into phytosiderophore biosynthesis. 
Phytosiderophore is a substance released by a grass root system into soil that dis-
solves iron and in such a way makes it accessible for plants. Yield of rice trans-
formed by these genes was four fold-higher than one of the original genotype, and 
quality also improved (TAKAHHASHI et al., 2001).  
Transformation methods alongside with methods of the GMO detection 
either in the original form or in products obtained from GMO were developed. 
Some restrictions of the detection method have to be emphasized. In Europe, a law 
related to food includes a regulation of a high protection level of health and safety 
of consumers, as well as, the requirement to establish the legislation primarily on 
scientific results and risk estimations. New types of food are defined as food not 
abundantly used and are estimated and classified within EC (European Commis-
sion, 2001) as: 
- elementary equivalent to traditional referent food;  
- sufficiently similar to traditional referent food and 
- insufficiently equivalent or similar to traditional referent food. 
In a genetically modified organism (GMO) a transgenic product presents a 
difference between the original and modified genotype. During the comparative 
studies on possibilities of occurrence of side effects of genetic modification it is 
useful to compare GMO with original genotypes under identical conditions. If the 
comparison proves isogeny of GMO and the original type, except for the foreign 
gene introduced by transformation, statistically significant differences can be in-
dicative of the existence of secondary effects (ANONYMOUS, 1999).  
Genetically modified plants can differ from non-modified ones due to the 
fact that they contain either a new specific DNA sequence and/or a specific new 
protein not present in the analogous product. Methods currently applied in the de-
tection of genetic modifications are based on the following: (i) DNA detection by 
which modification was performed (method of DNA multiplication based on po-
lymerase chain reaction - PCR method) and (ii) detection of the appropriate trans-
genic protein product by immunological methods (ANONYMOUS, 1999). 
An amount of a particular protein present in a sample that can contain 
many other proteins can be detected by immunological methods (ELISA). The 
method uses an antibody to bind a specific protein and an antibody conjugate and 
an enzyme that can metabolize a colored product that can be visualized and quanti-
fied. The quantified assay is in the form of a plate or a band.  
The PCR method is based on the detection of a DNA fragment introduced 
into a plant genome. This method allows multiplication of specific DNA sequences 
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up to the extent that they can be quantitatively and qualitatively analyzed. The 
majority of the methods based on the PCR is of high quality, sensitive and can de-
tect one or several gene copies. The presence of regulatory sequences (35S pro-
moter, nos terminator), marker genes and genes with which transformation was 
performed can be detected by the use of specific oligonucleotides. The advantage 
of the PCR-based method over the immunological method is that this method pro-
vides the detection of genetically modified DNA in samples which were thermally 
or chemically treated in their processing. The quantitative PCR-method will be 
used to determine the level of genetically modified components in food.  
Genomic technology, such as genome sequencing and expression, on the 
whole led biological sciences to the level of informatics and the use of the term 
bioinformatics. This expression is used to describe the scope of methods and ac-
tivities within information systems formed for processing and exchange of data 
obtained under laboratory conditions, interpretation and integration of data, prepa-
ration of documents and electronic issues of data related to sequences, mapping 
and data bases (BOGUSKI, 1994). 
The European Community has enacted a law by which a compulsory la-
beling of food with over 1% of substrates from genetically modified organisms 
(GMO) has been anticipated. The way of sampling outside of laboratories has be-
come an essential question. One of the examples is seed sampling from containers 
for seed storage or seed transport. Another example is a variability of GMO : non-
GMO ratio in a multiplied "homogenous" sample in a laboratory. These two exam-
ples point to the problem of the detection of the GMO presence in food. 
The regulation of the use of transgenic plants has to be based on the sci-
entific principles that provide health safety and the acceptable price of food pro-
duced from them that also recognize a low risk of gene transfer technologies and 
clearly define benefits of growers of such plants, food producers and consumers of 
such food. 
COMMERCIALISATION 
Commercial cultivation of genetically modified plants directly depends on 
the following:  
- the evaluation of traits under field conditions of cultivation; 
- the success of breeding and seed production for cultivation on large ar-
eas,  
-  the choice of optimal growing systems and  
- the release of new biotypes and protection of rights to intellectual prop-
erty. 
The improvement of the plant breeding process is achieved so rapidly that 
commercial cultivation depends on the legislation, protection of rights to intellec-
tual property and public acceptance. Patenting genetically modified organisms is 
designated as a key step in compensation of expenses related to the development of 
plants with significantly new traits. According to DIAMOND vs. CHRABARTY 
(1980) micro organisms could not have been patented because they had been living 
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organisms. In 1985, the US Patent Office enacted the law, which enabled patenting 
plants (Ex parte HIBBERD, 1985). 
The total global area sown with genetically modified crops increased from 
1.7 M ha in 1996 to 52.6 M ha in 2001 (JAMES, 2001). The greatest areas are in the 
USA (35.7 M ha), then Argentina (11.8 M ha), Canada (3.2 M ha) and China (1.5 
M ha). In Europe, genetically modified crops are grown in Romania, Bulgaria, 
Spain, Germany and France. Genetically modified crops were observed in 1668 
trials under field conditions in the European Community during 2001 (EUROPEAN 
COMMISSION, 2001). The largest areas of 33.3 M ha, then 9.8 M ha, 6.8 M ha and 
2.7 M ha were sown with genetically modified soy bean, then maize, cotton and oil 
seed rape, respectively. Genetically modified sweet maize, earth nut, pumpkin and 
papaya have been grown to a smaller extent (BIO, 1998). Out of global total areas 
sown with soy bean, i.e. cotton, approximately 46%, i.e. 20%, respectively, are 
sown with genetically modified plants. Total areas under genetically modified 
maize and oil seed rape do not differ from those in 2000.  
The utilization of genetic modification (GM) technologies in Europe is 
currently related to many discussions arisen from strong opposing to consumption 
of food produced from genetically modified plants, especially to the utilization of 
soybean meal in feed production (BROOKES, 2002). Meal produced from oil seed 
crops has been intensively used in feed as a source of proteins. Different meals 
have different nutritive values and soybean meal is considered the essential ingre-
dient of feed. The total soybean meal production in the EC amounts to 27 M tons 
and the greatest percentage of it is used in feed. The main reason for this is the fact 
that soybean meal contains 44-50% of proteins. The USA, Brazil and Argentina are 
the most important sources The majority of soybean crops in two principal sources, 
USA and Argentina, are genetically modified (GM), hence the greatest part of soy-
bean meal used in the EC for feed production originates from GM genotypes. 
During this and the following year (BROOKES, 2002), fundamental changes in GM 
and non GM soybean markets are predicted in several directions: (i) a great support 
to the movement for utilization of non-modified soybean in England; (ii) amounts 
of non-modified soybean are expected to be 22-25 M tons, but if requirements of 
the Asian market are included the necessary quantities will amount to 30 M tons; 
(iii) due to the growth of genetically modified soybean, by the introduction of the 
gene that control tolerance to herbicides (Roundup Ready Soybeans), in Argentina 
and Brazil, a drop of a quantity of non-modified soybean to 20-25 M tons is ex-
pected. Based on general forecasts, the increase of requirements for non-modified 
soybean is expected, meaning the increase of the number of countries-producers 
with a possibility to apply a strict legislation on growth and utilization of GM or-
ganisms and products-based on them is expected. One of certain consequences is 
the increase of prices of meat and other products originating from animals not fed 
on genetically modified soybean, while the respond of consumers will be interest-
ing (HMSO, 2000) 
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BIOTECHNOLOGY APPLICATION WITHIN NON-AGRICULTURAL FIELDS 
The utilization of transgenic plants in the production of special chemical 
products is also a great possibility. Plants were traditionally a raw material for the 
production of broad spectrum polymers - from starch and cellulose, belonging to 
carbohydrates, to polyhydrocarbons, such as gum and waxes. During the last dec-
ades, many of these products were substituted by the synthesis based on oil deri-
vates. Problems of different types related to the utilization of oil derivates have 
been causing ever increasing attention and studies on biological polymers. Genetic 
engineering will significantly increase a spectrum and content of accessible bio-
polymers. Transgenic plants present a potential of the production of foreign pro-
teins with various applications in medicine. Proteins as neuropeptides, factors of 
blood or growth promoters can be produced in plant seeds. Several proteins of the 
animal origin have already been produced in transgenic plants (EICHHOLTZ et al., 
1987; LEFEBVRE et al., 1987; BARTE et al., 1986), while the synthesis of pharma-
ceutical proteins has been performed in oil seed rape. Progress was achieved in the 
development of transgenic plants performing the synthesis of drugs and medicines: 
a transgenic plant was used simultaneously as food and vaccine (KONG et al., 
2001), or in another case, a transgenic plant was an intermediary host used for ex-
traction and filtration of interesting pharmaceutical substances (recombinant pro-
teins such as antibodies, hormones or blood factors, for instance).  
It is known that the tomato contains carotenoid lycopene with a protection 
effect against prostate cancer. Besides, fruit skin contains small amounts of flavon-
oids, potentially very strong antioxidants. MUIR et al. (2001) performed tomato 
transformation by the introduction of a gene from petunia that controlled the syn-
thesis of the enzyme involved into flavonol biosynthesis. Fruit skins of transgenic 
plants contain up to 78 fold higher amounts of flavonol in relation to the original 
genotype and present a good raw material for the pharmaceutical industry in pro-
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I z v o d  
 
Razvoj molekularne biologije i molekularne genetike posebno tehnologije 
rekombinantne DNK uz istovremeno usavršavanje tehnologija koje omogućavaju 
manipulacije u bezćelijskom sistemu kao što su kultura ćelija i tkiva rezultirao je u 
formiranju oblasti biotehnologije sa specifičnim osobinama u odnosu na klasične 
definicije. Integracijom najpropulzivnijih naučnih disciplina kao što su biologija, 
biohemija, molekularna biologija, genetika, hemijski inženjering i informatika ot-
vorene su neograničene mogučnosti i izazovi u sprečavanju bolesti humane popu-
lacije, biljaka i životinja, kontroli insekata bez pesticida, povećanju produktivnosti 
stoke, povećanju proizvodnje i poboljšanju kvaliteta hrane i redukciji životne 
sredine. Osnovne komponente moderne biotehnologije, prema Presley-u i Lantin 
(2000) su: (i) genomika – molekularna karakterizacija svih gena i produkata gena 
organizma; (ii) bioinformatika – organizovanje podataka dobijenih iz analize ge-
noma u prihvatljivu formu; (iii) transformacija – unošenje gena koji kontroliše 
osobinu od interesa u genom željenog organizma (mikroorganizmi, biljke, animalni 
sistemi) i (iv) dijagnostika – brža i pouzdanija identifikacija prisustva ili odsustva 
gena u genomu organizma od interesa (identifikacija patogena, prenatalna dija-
gnostika, molekularno oplemenjivanje biljaka korišćenjem molekularnih markera i 
sl.). Svojstva organizma su određena njegovim genetičkim materijalom, odnosno 
molekulom dezoksiribonukleinske kiseline (DNK). Watson i Crick (1953) su prvi 
objasnili strukturu molekula DNK kao dvolančane zavojnice. Viši organizmi sa-
drže set linearnih DNK molekula - hromozoma i kompletan set hromozoma or-
ganizma je genom. Svaki genom je podeljen u serije funkcionalnih jedinica od-
nosno gena. Svojstva organizma zavise od gena ali njihovo ispoljavanje zavisi i od 
mnogih drugih faktora, uključujući da li se gen odgovoran za tu osobinu eks-
primira, specifičnih ćelija u kojima se eksprimira a posebno kako gen i njegov pro-
dukt intereaguju sa spoljašnjom sredinom. Poseban aspekt u okviru korišćenja 
biotehnologije se javlja kao interakcija stranog gena sa genomom organizma u koji 
je integrisan. Primena tehnologije rekombinatne DNK ima nekoliko prednosti u 
odnosu na tradicionalno oplemenjivanje. Genetičke modifikacije biljaka kao i 
klasično oplemenjivanje imaju isti cilj, dobijanje biljaka sa poboljšanim 
svojstvima. Klasičnim metodama oplemenjivanja prenosi se kompletan set gena iz 
roditeljskih linija u novo potomstvo. Time se ne prenosi samo jedan ili dva željena 
gena već stotine drugih gena, neki poželjni, a neki ne. Takođe, tradicionalne me-
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tode oplemenjivanja se zasnivaju na prenosu genetičkog materijala između jedinki 
iste ili veoma bliske vrste. Primenom biotehnologije moguće je preneti jedan ili 
više poželjnih gena iz bilo koje evolucione kategorije u istu ili drugu kategoriju 
organizma i na taj način stvoriti genetički modifikovane organizme (GMO) sa že-
ljenim osobinama. U radu će biti dat pregled stanja u oblasti primene bio-





Primljeno 1. X 2002.  
Odobreno 16. XII 2002. 
 
